State of the Art: Surgery for Gynecologic Oncology
Deadline for manuscript submissions: 25 April 2024 | Viewed by 84
Interests: gynecological cancers surgery; minimal invasive surgery; endometriosis
Interests: gynecological cancer surgery; immunology and genetic of tumor; ultraradical surgery for ovarian cancer; inflamma-tion and tumor; endometriosis
Surgery for gynecological cancers has been challenged in recent years by the intensification of treatment for ovarian cancer and, on the other hand, de-escalation for endometrial and cervical cancer surgery. HIPEC (hyperthermic intra peritoneal chemotherapy) has emerged as an option in the management of recurrent ovarian cancer and is under investigation as a first-line treatment. Sentinel lymph node biopsy has become a standard of care in early endometrial cancer, while the decision for adjuvant treatment is more and more guided by the risk profile of the endometrial cancer determined by both the histopathologic and the molecular classification of the tumor. The surgical approach (open surgery versus minimal invasive surgery) and the type of hysterectomy for cervical cancer have been questioned in both the LACC and the SHAPE trials.
The quality of life of the patients surviving cancer is as important as the efficacy of treatments and needs to be discussed when proposing therapeutic options to women diagnosed with a gynecological cancer.
Survival after the standard first-line treatment is often very variable and difficult to predict. Variables with an impact on survival during the treatment are more and more considered.
We propose, in this Special Issue, to address most of the novel medico-surgical strategies in the treatment of gynecological cancer. We also propose presenting original results such as the impact of inflammation during debulking surgery for ovarian cancer on patients’ survival.
Dr. Maxime Fastrez
Dr. Mathieu Luyckx
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gynecological cancer
- minimally invasive surgery
- novel strategy
- quality of life